4//SEC Filing
DAVIE JOSEPH MD PHD 4
Accession 0001181431-09-028196
CIK 0000921114other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 11:43 AM ET
Size
5.7 KB
Accession
0001181431-09-028196
Insider Transaction Report
Form 4
DAVIE JOSEPH MD PHD
Director
Transactions
- Award
Stock option (right to buy)
2009-05-29+60,000→ 60,000 totalExercise: $0.27Exp: 2019-05-29→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable over a two-year period, as follows: 25% of the option shares vested and become exercisable on the date of grant, and the remaining 75% of the option shares will vest and become exercisable in two equal installments on the first and second anniversaries of the date of grant.
Documents
Issuer
TARGETED GENETICS CORP /WA/
CIK 0000921114
Entity typeother
Related Parties
1- filerCIK 0001216660
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 11:43 AM ET
- Size
- 5.7 KB